The Chemist’s Lens of Sickle Cell Disease: Molecular Mechanisms, Biophysical Dynamics, Tissue Pathology, and Emerging Chemical Therapeutics — A Critical Review
World Scientific News · 2026
DOI: 10.65770/fpyd6165 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Scientific News, 2026. Verfasst von Kanayo Samuel Okonji und 3 weiteren Autor:innen. Die Arbeit nennt 167 Literaturangaben.
Abstract (Originalsprache)
Sickle Cell Disease (SCD) is a monogenic hemoglobinopathy arising from a single point mutation in the β-globin gene (Glu6Val), which replaces a polar glutamic acid residue with a hydrophobic valine in the β-chain of hemoglobin. Although structurally subtle, this substitution fundamentally alters intermolecular interactions within deoxygenated hemoglobin, promoting hydrophobic association, nucleation, and polymerization of hemoglobin S (HbS). The resulting supramolecular fiber formation drives erythrocyte deformation, membrane fragility, hemolysis, vaso-occlusion, and progressive tissue and organ injury. From a chemical standpoint, SCD represents a paradigmatic example of how atomic-scale perturbations propagate across hierarchical levels, from molecular structure and intermolecular interactions to cellular dysfunction, tissue injury, and systemic disease. In this review, we synthesize evidence from more than 160 peer-reviewed studies to examine the chemistry of HbS polymerization, intermolecular thermodynamics, reaction kinetics, redox imbalance, membrane oxidative damage, and the biophysical determinants of sickling. Particular emphasis is placed on the physical chemistry governing nucleation dynamics, allosteric modulation of oxygen affinity, and reactive oxygen species (ROS) generation within sickled erythrocytes. The review further connects these molecular and cellular processes with the pathological consequences observed at the tissue and organ levels, including microvascular injury, ischemia–reperfusion damage, chronic inflammation, fibrosis, and characteristic structural alterations in organs affected by SCD. This pathology-centered perspective provides a bridge between molecular mechanisms and the morphological manifestations of chronic sickle cell injury. We also evaluate emerging chemical therapeutics, including allosteric hemoglobin modifiers, antisickling agents, redox modulators, and fetal hemoglobin inducers, through the lens of structure–activity relationships and mechanistic biochemistry. Analytical and computational approaches, including spectroscopy, crystallography, molecular docking, molecular dynamics simulations, and histopathological assessment, are discussed as complementary platforms for linking molecular events with cellular and tissue-level phenotypes and for guiding rational therapeutic development. By integrating molecular chemistry, biophysical dynamics, tissue pathology, and translational pharmacology, this review provides a chemist-centered framework that reframes SCD not merely as a genetic disorder, but as a disorder in which altered molecular interactions propagate through cellular, tissue, and organ systems to produce pathological remodeling, thereby highlighting new avenues for chemically informed therapeutic innovation.
Zitieren
APA
Okonji, K. S., Daramola, A. O., Folaranmi, O. E., & Alade, O. T. (2026). The Chemist’s Lens of Sickle Cell Disease: Molecular Mechanisms, Biophysical Dynamics, Tissue Pathology, and Emerging Chemical Therapeutics — A Critical Review. World Scientific News. https://doi.org/10.65770/fpyd6165
Vancouver
Okonji KS, Daramola AO, Folaranmi OE, Alade OT. The Chemist’s Lens of Sickle Cell Disease: Molecular Mechanisms, Biophysical Dynamics, Tissue Pathology, and Emerging Chemical Therapeutics — A Critical Review. World Scientific News. 2026. doi:10.65770/fpyd6165
BibTeX
@article{Okonji2026,
author = {Okonji, Kanayo Samuel and Daramola, Alaba Olanrewaju and Folaranmi, Olufemi Ebenezer and Alade, Olugbenga Tosin},
title = {The Chemist’s Lens of Sickle Cell Disease: Molecular Mechanisms, Biophysical Dynamics, Tissue Pathology, and Emerging Chemical Therapeutics — A Critical Review},
journal = {World Scientific News},
year = {2026},
doi = {10.65770/fpyd6165}
}
EUVIMED